White label ELPA - ClinicalTrials.eu

Study on the Safety and Effects of AZD7789 for Patients with Relapsed or Refractory Classical Hodgkin Lymphoma

Not recruiting

1 1 1 1
Investigated diseases:
- Hodgkin’s disease
Investigated drugs:
Study of Risankizumab vs. Placebo for Patients with Active Psoriatic Arthritis and Inadequate Response to DMARD Therapy

Not recruiting

3 1
Investigated drugs:
- Risankizumab
+11
Study on Trastuzumab Emtansine, Pertuzumab, and Atezolizumab for Patients with HER2-Positive Metastatic Cancer Who Benefited from Previous Treatment

Not recruiting

2 1 1 1
Investigated drugs:
Study on the Effects and Safety of Crovalimab for Adults and Adolescents with Atypical Hemolytic Uremic Syndrome (aHUS)

Not recruiting

3 1 1
Investigated diseases:
- Atypical haemolytic uraemic syndrome
Investigated drugs:
- Crovalimab
+1
Study Comparing Nivolumab and Ipilimumab with Chemotherapy to Chemotherapy Alone for Patients with Stage IV Non-Small Cell Lung Cancer

Not recruiting

3 1 1 1
Investigated diseases:
- Non-small cell lung cancer stage IV
Investigated drugs:
+1
Study of Daratumumab with Drug Combination for Patients with Newly Diagnosed Multiple Myeloma Eligible for High-Dose Therapy

Not recruiting

3 1 1 1
Investigated diseases:
- Plasma cell myeloma
Investigated drugs:
+5
Study on Tisagenlecleucel for High-Risk B-Cell Acute Lymphoblastic Leukemia in Pediatric and Young Adult Patients with Minimal Residual Disease

Not recruiting

2 1 1 1
Investigated diseases:
- Acute lymphocytic leukaemia recurrent
Investigated drugs:
- Tisagenlecleucel
+2
Study of Tobemstomig with Platinum-Based Chemotherapy vs Pembrolizumab with Platinum-Based Chemotherapy for Untreated Non-Small Cell Lung Cancer Patients

Not recruiting

2 1 1 1
Investigated diseases:
- Non-small cell lung cancer
Study of Apalutamide and Androgen Deprivation Therapy for Patients with Metastatic Hormone-sensitive Prostate Cancer

Not recruiting

3 1 1
Investigated diseases:
- Prostate cancer metastatic
Investigated drugs:
- Apalutamide
Study on the Safety and Effectiveness of LASN01 for Patients with Thyroid Eye Disease

Not recruiting

2 1 1
Investigated diseases:
- Endocrine ophthalmopathy
Investigated drugs:

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies